The Journal of thoracic and cardiovascular surgery
-
J. Thorac. Cardiovasc. Surg. · Jul 2024
Mechanical versus Biological Mitral Valve Replacement: Insights from Propensity Score Matching on Survival and Reoperation Rates.
Patients with symptomatic mitral valve disease unsuitable for repair can be sufficiently treated with surgical mitral valve replacement. The decision between biological and mechanical mitral valve replacement can be difficult, especially due to the question of the lesser of 2 evils: anticoagulation versus reoperation. ⋯ Follow-up of 20 years at a high-volume center demonstrates comparable survival after mechanical or biological mitral valve replacement, whereas reoperation rates are significantly lower after mechanical mitral valve replacement.
-
J. Thorac. Cardiovasc. Surg. · Jul 2024
Development of American Association for Thoracic Surgery Quality Gateway Outcome Models, Analytics, and Visualizations for Quality Assurance.
The study objective was to develop comprehensive quality assurance models for procedural outcomes after adult cardiac surgery. ⋯ By using a small set of variables and contemporary machine-learning methods, comprehensive models for procedural operative mortality and major morbidity after adult cardiac surgery were developed based on data from 3 exemplary hospital systems. They provide surgeons, their patients, and hospital systems with 21st century tools for assessing their risks compared with these advanced hospital systems and improving cardiac surgery quality.
-
J. Thorac. Cardiovasc. Surg. · Jul 2024
EditorialThe Evolution of the Treatment of Non-small Cell Lung Cancer: A Shift in Surgical Paradigm to A More Individualized Approach.
Surgical treatment is an integral part of the comprehensive therapeutic methods for lung cancer, especially for early-stage non-small cell lung cancer (NSCLC). With a deeper understanding of the disease, we found that lung cancer is more commonly detected in young females. For regions of Asia, more lung cancer has been detected in early-stage GGO-dominant non-smokers. ⋯ However, the pursuit of lung-sparing individualized approaches has raised worldwide attention. Suitable surgical treatment within the curative time window is recommended to maximize the long-term benefit. This article summarizes the shift in surgical treatment for small NSCLCs and hopes to enlighten further innovations to fill in the gaps between the unmet needs and a more individualized approach.